NCLH vs UTHR · P/E 16, rev $4.97B vs P/E 20, rev $1.56B
Norwegian Cruise Line Holdings Ltd (NCLH) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the NCLH and UTHR stock pages for the full models.
Not investment advice.